查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1224595

静脉 (IV) 输液泵市场规模、份额和趋势分析报告：按产品（电容式、胰岛素、注射器、肠内、门诊）、疾病适应症、地区、细分市场预测，2023-2030 年

Intravenous Infusion Pump Market Size, Share & Trends Analysis Report By Product (Volumetric, Insulin, Syringe, Enteral, Ambulatory), By Disease Indication, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

静脉 (IV) 输液泵市场增长和趋势

根据 Grand View Research, Inc. 的一份新报告预计，到 2030 年，全球静脉 (IV) 输液泵市场将达到 99 亿美元，2023 年至 2030 年的复合年增长率为 8.3%。 专业化和智能化泵的引进和开发是输液泵行业决定性增长的原因。 智能输液泵被认为是市场的推动力，因为它们结合了错误减少软件和定製药物库。 迈瑞医疗2018年的一项研究显示，输液泵是最传统的医院租赁设备。

心血管和癌症等新发疾病继续推动对静脉 (IV) 输液泵设备的需求。 静脉 (IV) 输液泵可确保药物和营养素的调节、控制和无差错输送。 当用化学疗法和放射疗法治疗患者时，这些过程是必不可少的。 这些都是非常复杂的过程，需要非常精确的药物剂量。 输液泵设备创新、自动化和标准化剂量等因素的结合有望使患者的治疗更加方便和用户友好。

由于 COVID-19 大流行，2020 年静脉 (IV) 输液泵行业的需求出现增长。 这是因为输液泵是最常用于突发卫生事件的医疗设备。 由于大流行病导致医疗设施使用量增加，对输液泵等医疗设备的需求大幅飙升。 2020年5月，FDA还对输液泵和输液泵配件的紧急使用进行了全面授权。 医疗保健提供者的这种增加的使用响应了对输液泵的增加的需求。

静脉 (IV) 输液泵市场报告要点

容量输液泵已成为 2022 年最大的产品细分市场，原因是在紧急情况和化疗等治疗中越来越多地使用营养液和药物等输送流体

随着全球糖尿病负担的增加，预计胰岛素输注泵在预测期内的复合年增长率最高

随着早产对最佳护理和营养需求的增加，儿科/新生儿领域在 2022 年的疾病适应症方面占据市场主导地位

由于老年人口和糖尿病人口的增加，预计亚太地区在预测期内将经历最快的增长

内容

第一章调查方法及范围

  • 市场细分和范围
    • 产品
    • 适应症
    • 区域范围
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细信息
    • 商品流分析（模型 1）
    • 批量价格分析（模型 2）
  • 二级信息列表
  • 主要信息列表
  • 目的

第 2 章执行摘要

  • 市场展望
  • 细分市场展望
  • 竞争考虑

第 3 章静脉 (IV) 输液泵市场变量、趋势和范围

  • 市场系列展望
    • 母公司市场展望
    • 相关/子公司市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场製约因素分析
    • 行业问题
  • 静脉泵：市场分析工具
    • 行业分析 - 搬运工
    • PESTEL 分析
    • 对主要交易和战略联盟的分析
    • COVID-19 影响分析

第 4 章静脉 (IV) 输液泵市场：按产品细分分析，2018-2030 年（百万美元）

  • 定义和范围
  • 2018 年和 2030 年产品市场份额分析
  • 部门仪表板
  • 全球输液泵市场，按产品分类，2022-2030 年
  • 以下2018-2030年市场规模及预测，趋势分析
    • 按产品分类
      • 容量输液泵
      • 胰岛素输注泵
      • 注射器输液泵
      • 肠内输液泵
      • 便携式输液泵
      • 患者自控镇痛 (PCA)
      • 植入式输液泵
      • 其他

第 5 章静脉 (IV) 输液泵市场：按疾病适应症细分分析，2018-2030（百万美元）

  • 定义和范围
  • 2022 年和 2030 年疾病适应症的市场份额分析
  • 部门仪表板
  • 按疾病适应症划分的全球静脉 (IV) 输液泵市场，2018-2030 年
  • 以下2018-2030年市场规模及预测，趋势分析
    • 化疗
    • 糖尿病
    • 胃肠病学
    • 镇痛和疼痛管理
    • 儿科和新生儿科
    • 血液学
    • 其他

第 6 章静脉 (IV) 输液泵市场：区域市场分析，按产品，2018-2030 年（百万美元）

  • 定义和范围
  • 2022 年和 2030 年区域市场份额分析
  • 区域市场仪表板
  • 区域市场概况
  • 2022 年区域市场份额
  • 2018-2030 年市场规模、预测和趋势分析：
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 荷兰
    • 比利时
    • 瑞士
    • 俄罗斯
    • 瑞典
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 马来西亚
    • 印度尼西亚
    • 新加坡
    • 菲律宾
    • 泰国
    • 新西兰
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 智利
  • 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 埃及

第 7 章静脉 (IV) 输液泵市场-竞争分析

  • 主要市场进入者的近期趋势和影响分析
  • 公司/竞争对手分类（主要创新者、市场领导者、初创企业）
    • 参与公司
    • 创新者
  • 供应商情况
    • 主要服务提供商列表
      • 市场差异化因素
      • 输液泵 - 市场份额分析
  • 主要公司介绍
    • 百特国际
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • B.Braun Melsungen AG
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • 美敦力
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • 麦克雷尔医疗器械公司
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • 费森尤斯·卡比
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • 波士顿科学公司
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • CAREFUSION 公司
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • 史密斯医疗
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • F. Hoffmann-La Roche Ltd.
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • Tandem Diabetes Care, Inc.
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • 泰尔茂公司
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • 迈瑞
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • 穆格公司
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • IRadimed 公司
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
Product Code: GVR-4-68038-560-1

Intravenous Infusion Pump Market Growth & Trends:

The global intravenous infusion pump market size is expected to reach USD 9.9 billion by 2030 and is expected to expand at 8.3% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The introduction and development of specialty and smart pumps are responsible for the crucial growth of the infusion pump industry. Smart infusion pumps are considered an advancement that will give a boost to the market as it embeds error-reduction software and customized drug libraries. According to a study conducted by Mindray Medical company in 2018, infusion pumps are the most conventional hospital rental equipment.

The rise in diseases like cardiovascular and cancer continues to drive the demand for intravenous infusion pump devices. Intravenous infusion pumps ensure regulated, controlled, and error-free delivery of medications and nutrients. Such processes are essential while treating patients via chemotherapy or radiation therapy. These are very complex processes and require a very precise dosage of medication. The amalgamation of factors like shift in technology, automation, and standardized dosing for intravenous pump devices are anticipated to make therapy more convenient and user-friendly for patients.

The intravenous infusion pumps industry witnessed growth in demand in 2020 due to the COVID-19 pandemic. This was because infusion pumps are the most common medical devices used in health emergencies. As the pandemic burdened healthcare facilities due to increased use, the demand for medical devices like infusion pumps witnessed a major surge. In May 2020, the FDA also issued an umbrella authorization for the emergency use of infusion pumps and infusion pump accessories. This increased use by healthcare providers catered to the increased demand for infusion pumps.

Intravenous Infusion Pump Market Report Highlights:

  • Volumetric infusion pumps emerged as the largest product segment in 2022, owing to the increasing use of delivery fluids such as nutrients and medications during emergencies and treatments like chemotherapy
  • The insulin infusion pumps segment is projected to register the highest CAGR over the forecast period as the burden of diabetes increases globally
  • The pediatrics/ neonatology segment dominated the market in 2022 in terms of disease indication as there have been growing incidences of premature births, which require optimum care and nutrition
  • The Asia Pacific market is projected to witness the fastest growth over the forecast period owing to the increasing number of geriatric and diabetic patients in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Disease Indication
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Volume price analysis (Model 2)
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Intravenous Infusion Pumps Market Variables, Trends & Scope

  • 3.1. Market Lineage outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Industry Challenges
  • 3.3. Intravenous Infusion Pumps: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. Major Deals & Strategic Alliances Analysis
    • 3.3.4. COVID-19 Impact Analysis

Chapter 4. Intravenous Infusion Pumps Market: Segment Analysis, by Product, 2018 - 2030 (USD Million)

  • 4.1. Definitions & Scope
  • 4.2. Product market share analysis, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Intravenous Infusion Pumps Market, by Product, 2022 to 2030
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. By product
      • 4.5.1.1. Volumetric Infusion pumps
      • 4.5.1.2. Insulin Infusion pumps
      • 4.5.1.3. Syringe Infusion pumps
      • 4.5.1.4. Enteral Infusion pumps
      • 4.5.1.5. Ambulatory Infusion pumps
      • 4.5.1.6. Patient Controlled Analgesia (PCA)
      • 4.5.1.7. Implantable Infusion pumps
      • 4.5.1.8. Others

Chapter 5. Intravenous Infusion Pumps Market: Segment Analysis, By Disease Indication, 2018 - 2030 (USD Million)

  • 5.1. Definitions & Scope
  • 5.2. Disease Indication market share analysis, 2022 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Intravenous Infusion Pumps Market, By Disease Indication, 2018 to 2030
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Chemotherapy
    • 5.5.2. Diabetes
    • 5.5.3. Gastroenterology
    • 5.5.4. Analgesia/Pain Management
    • 5.5.5. Pediatrics/Neonatology
    • 5.5.6. Hematology
    • 5.5.7. Others

Chapter 6. Intravenous Infusion Pumps Market: Regional Market Analysis, by Product, 2018 - 2030 (USD Million)

  • 6.1. Definitions & Scope
  • 6.2. Regional Market Share Analysis, 2022 & 2030
  • 6.3. Regional Market Dashboard
  • 6.4. Regional Market Snapshot
  • 6.5. Regional Market Share, 2022
  • 6.6. Market Size, & Forecasts, and Trend Analysis, 2018 to 2030:
  • 6.7. North America
    • 6.7.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 6.7.2. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
    • 6.7.3. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.7.4. U.S.
      • 6.7.4.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.7.4.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.7.5. Canada
      • 6.7.5.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.7.5.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
  • 6.8. Europe
    • 6.8.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 6.8.2. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
    • 6.8.3. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.4. Germany
      • 6.8.4.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.4.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.5. U.K.
      • 6.8.5.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.5.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.6. France
      • 6.8.6.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.6.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.7. Italy
      • 6.8.7.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.7.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.8. Spain
      • 6.8.8.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.8.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.9. Netherlands
      • 6.8.9.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.9.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.10. Belgium
      • 6.8.10.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.10.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.11. Switzerland
      • 6.8.11.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.11.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.12. Russia
      • 6.8.12.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.12.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.8.13. Sweden
      • 6.8.13.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.8.13.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
  • 6.9. Asia Pacific
    • 6.9.1. Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 6.9.2. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
    • 6.9.3. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.4. China
      • 6.9.4.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.4.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.5. Japan
      • 6.9.5.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.5.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.6. India
      • 6.9.6.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.6.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.7. Australia
      • 6.9.7.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.7.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.8. South Korea
      • 6.9.8.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.8.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.9. Malaysia
      • 6.9.9.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.9.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.10. Indonesia
      • 6.9.10.1. Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.10.2. Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.11 Singapore
      • 6.9.11.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.11.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.12 Philippines
      • 6.9.12.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.12.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.13 Thailand
      • 6.9.13.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.13.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.9.14 New Zealand
      • 6.9.14.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.9.14.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
  • 6.10 Latin America
    • 6.10.1 Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 6.10.2 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
    • 6.10.3 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.10.4 Brazil
      • 6.10.4.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.10.4.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.10.5 Mexico
      • 6.10.5.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.10.5.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.10.6 Argentina
      • 6.10.6.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.10.6.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.10.7 Colombia
      • 6.10.7.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.10.7.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.10.8 Chile
      • 6.10.8.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.10.8.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
  • 6.11 Middle East and Africa
    • 6.11.1 Market estimates and forecast, by country, 2018 - 2030 (USD Million)
    • 6.11.2 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
    • 6.11.3 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.11.4 South Africa
      • 6.11.4.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.11.4.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.11.5 Saudi Arabia
      • 6.11.5.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.11.5.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.11.6 UAE
      • 6.11.6.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.11.6.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.11.7 Israel
      • 6.11.7.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.11.7.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)
    • 6.11.8 Egypt
      • 6.11.8.1 Market estimates and forecast, by Product, 2018 - 2030 (USD Million)
      • 6.11.8.2 Market estimates and forecast, by Disease Indication, 2018 - 2030 (USD Million)

Chapter 7 Intravenous Infusion Pumps Market - Competitive Analysis

  • 7.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
    • 7.2.1 Participant Categorization
    • 7.2.2 Innovators
  • 7.3 Vendor Landscape
    • 7.3.1 List of Key Service Providers
      • 7.3.1.1 Market Differentiators
      • 7.3.1.2 Intravenous Infusion Pumps- Market Share Analysis
  • 7.4 Key companies profiled
    • 7.4.1 Baxter International
      • 7.4.1.1 Company Overview
      • 7.4.1.2 Financial Performance
      • 7.4.1.3 Product Benchmarking
      • 7.4.1.4 Strategic Initiatives
    • 7.4.2 B. Braun Melsungen AG
      • 7.4.2.1 Company Overview
      • 7.4.2.2 Financial Performance
      • 7.4.2.3 Product Benchmarking
      • 7.4.2.4 Strategic Initiatives
    • 7.4.3 Medtronic
      • 7.4.3.1 Company Overview
      • 7.4.3.2 Financial Performance
      • 7.4.3.3 Product Benchmarking
      • 7.4.3.4 Strategic Initiatives
    • 7.4.4 Micrel Medical Devices Sa
      • 7.4.4.1 Company Overview
      • 7.4.4.2 Financial Performance
      • 7.4.4.3 Product Benchmarking
      • 7.4.4.4 Strategic Initiatives
    • 7.4.5 Fresenius Kabi
      • 7.4.5.1 Company Overview
      • 7.4.5.2 Financial Performance
      • 7.4.5.3 Product Benchmarking
      • 7.4.5.4 Strategic Initiatives
    • 7.4.6 Boston Scientific Corporation
      • 7.4.6.1 Company Overview
      • 7.4.6.2 Financial Performance
      • 7.4.6.3 Product Benchmarking
      • 7.4.6.4 Strategic Initiatives
    • 7.4.7 CAREFUSION CORPORATION
      • 7.4.7.1 Company Overview
      • 7.4.7.2 Financial Performance
      • 7.4.7.3 Product Benchmarking
      • 7.4.7.4 Strategic Initiatives
    • 7.4.8 Smiths Medical
      • 7.4.8.1 Company Overview
      • 7.4.8.2 Financial Performance
      • 7.4.8.3 Product Benchmarking
      • 7.4.8.4 Strategic Initiatives
    • 7.4.9 F. Hoffmann-La Roche Ltd.
      • 7.4.9.1 Company Overview
      • 7.4.9.2 Financial Performance
      • 7.4.9.3 Product Benchmarking
      • 7.4.9.4 Strategic Initiatives
    • 7.4.10 Tandem Diabetes Care, Inc.
      • 7.4.10.1 Company Overview
      • 7.4.10.2 Financial Performance
      • 7.4.10.3 Product Benchmarking
      • 7.4.10.4 Strategic Initiatives
    • 7.4.11 Terumo Corporation
      • 7.4.11.1 Company Overview
      • 7.4.11.2 Financial Performance
      • 7.4.11.3 Product Benchmarking
      • 7.4.11.4 Strategic Initiatives
    • 7.4.12 Mindray
      • 7.4.12.1 Company Overview
      • 7.4.12.2 Financial Performance
      • 7.4.12.3 Product Benchmarking
      • 7.4.12.4 Strategic Initiatives
    • 7.4.13 Moog Inc.
      • 7.4.13.1 Company Overview
      • 7.4.13.2 Financial Performance
      • 7.4.13.3 Product Benchmarking
      • 7.4.13.4 Strategic Initiatives
    • 7.4.14 IRadimed Corporation
      • 7.4.14.1 Company Overview
      • 7.4.14.2 Financial Performance
      • 7.4.14.3 Product Benchmarking
      • 7.4.14.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Intravenous Infusion Pumps Market, By Region 2018 - 2030 (USD Million)
  • Table 4 Global Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 Global Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 6 North America Intravenous Infusion Pumps Market, By Country, 2018 - 2030 (USD Million)
  • Table 7 North America Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 8 North America Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 9 U.S. Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 U.S. Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 11 Canada Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 12 Canada Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 13 Europe Intravenous Infusion Pumps Market, By Country, 2018 - 2030 (USD Million)
  • Table 14 Europe Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 Europe Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 16 U.K. Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 17 U.K. Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 18 Germany Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 Germany Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 20 France Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 France Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 22 Italy Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Italy Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 24 Spain Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 25 Spain Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 26 Netherlands Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 Netherlands Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 28 Belgium Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 29 Belgium Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 30 Switzerland Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Switzerland Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 32 Russia Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 33 Russia Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 34 Sweden Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 35 Sweden Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Intravenous Infusion Pumps Market, By Country, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 39 India Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 40 India Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 41 Japan Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 42 Japan Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 43 China Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 44 China Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 45 Australia Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 46 Australia Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 47 South Korea Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 48 South Korea Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 49 Malaysia Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 50 Malaysia Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 51 Indonesia Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 52 Indonesia Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 53 Singapore Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 54 Singapore Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 55 Philippines Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 Philippines Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 57 Thailand Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 58 Thailand Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 59 Thailand Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 Thailand Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 61 Latin America Intravenous Infusion Pumps Market, By Country, 2018 - 2030 (USD Million)
  • Table 62 Latin America Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 63 Latin America Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 64 Brazil Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 65 Brazil Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 66 Mexico Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 67 Mexico Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 68 Argentina Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 69 Argentina Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 70 Colombia Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 71 Colombia Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 72 Chile Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 73 Chile Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 74 MEA Intravenous Infusion Pumps Market, By Country, 2018 - 2030 (USD Million)
  • Table 75 MEA Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 76 MEA Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 77 South Africa Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 78 South Africa Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 81 UAE Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 82 UAE Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 83 Israel Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 84 Israel Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 85 Egypt Intravenous Infusion Pumps Market, By Product, 2018 - 2030 (USD Million)
  • Table 86 Egypt Intravenous Infusion Pumps Market, By Disease Indication, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Intravenous Infusion Pumps Market: Market snapshot
  • Fig. 8 Intravenous Infusion Pumps Market: Market segmentation
  • Fig. 9 Intravenous Infusion Pumps Market Strategy Framework
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Intravenous Infusion Pumps Market driver impact
  • Fig. 13 Intravenous Infusion Pumps Market restraint impact
  • Fig. 14 Intravenous Infusion Pumps Market Porter's Five Forces Analysis
  • Fig. 15 Intravenous Infusion Pumps Market PESTEL analysis
  • Fig. 16 Intravenous Infusion Pumps Market segment dashboard
  • Fig. 17 Intravenous Infusion Pumps Market: Product Movement Analysis
  • Fig. 18 Infusion pumps estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Intravenous Sets estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 IV cannulas estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Volumetric Infusion Pumps estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Insulin Infusion Pumps Market segment dashboard
  • Fig. 23 Intravenous Infusion Pumps Market: Disease Indication Movement Analysis
  • Fig. 24 Chemotherapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Endocrinology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Gastroenterology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Analgesia/ Pain management market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Pediatrics/neonatology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Global Intravenous Infusion Pumps Market: Regional movement analysis
  • Fig. 33 Global Intravenous Infusion Pumps Market: Regional outlook and key takeaways
  • Fig. 34 Global market share, by region
  • Fig. 35 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Netherlands market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Belgium market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Switzerland market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Russia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Malaysia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Indonesia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Singapore market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Philippines market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Colombia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Chile market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Israel market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Egypt market estimates and forecast, 2018 - 2030 (USD Million)